Proportion of Patients 40–70 Years of Age With Very High Risk for Atherosclerotic Cardiovascular Disease and a Baseline Low-Density Lipoprotein Cholesterol ≥1.8 mmol/L (≥70 mg/dL) Who Are Prescribed Lipid Lowering Therapy
Identifying Attributes
Care Settings
Country
Publishing Organisation
Type of Quality Indicator
IOM Quality Dimension
Domain
Defining Attributes
Definition
Proportion of patients 40–70 years of age with very high risk for atherosclerotic cardiovascular disease (ASCVD) and a baseline low-density lipoprotein cholesterol (LDL-C) ≥1.8 mmol/L (≥70 mg/dL) who are prescribed lipid lowering therapy.
Numerator
Patients between 40 and 70 years of age with very high risk for ASCVD and a baseline LDL-C ≥1.8 mmol/L (≥70 mg/dL) who are prescribed lipid lowering therapy.
Denominator
Patients between 40 and 70 years of age with very high risk for ASCVD and a baseline LDL-C ≥1.8 mmol/L (≥70 mg/dL) who have no contraindication, refusal, or history of intolerance to lipid lowering therapy.
Exclusions
Use of Risk Adjustment
Risk Adjustments
Stratifications
Collection and Reporting Attributes
Type of Data Collection
Data Collection Methods
Frequency of Data Collection
Frequency of Data Collection in Days
Reporting Methods
Reporting Frequency
Reporting Frequency in Days
Indicator Has Recommended Targets
Source and Reference Attributes
Evidence Source
Aktaa S, Gencer B, Arbelo E, Davos CH, Désormais I, Hollander M, et al. European Society of Cardiology Quality Indicators for Cardiovascular Disease Prevention: developed by the Working Group for Cardiovascular Disease Prevention Quality Indicators in collaboration with the European Association for Preventive Cardiology of the European Society of Cardiology. Eur J Prev Cardiol. 2022;29(7):1060-71.